Welcome to Dundee Cell Proteomics

Dundee Cell Proteomics provides pharmaceutical and biotech companies with novel technologies and proteomics services to support the development of safer drugs faster. We are best placed to apply our knowledge and experience in a wide range of bioscience disciplines including quantitative proteomics, chemical biology, biochemistry, molecular biology, bioinformatics and cell biology to provide solutions in key areas of drug discovery and development.

We have developed a quantitative proteomics-based technology portfolio that offers solutions to preclinical activities of the drug discovery process and developed new processes for biomarker discovery and validation, drug reprofiling and repositioning.

At the preclinical stages of drug development, our technologies support decision making including the ability to predict potential toxicity liabilities as well as cellular mechanisms of action of compounds under development. A clear understanding of a compound’s mechanism of action at the molecular level in the complex cellular environment is essential in predicting potential undesirable side-effects that may result from using the compound as a drug.